PlasmaTech Biopharmaceuticals (PTBI): Soros Fund Reveals 5.17 Percent Stake

George Soros’s Fund Management has taken a new 1.16 million share, or 5.17%, stake in PlasmaTech Biopharmaceuticals (PTBI). In after hours trade on Monday, PlasmaTech shares were up $1.43, or 50.00%, to $4.24. Soros’s latest 13G filing with the SEC shows that the investing legend’s fund increased its stake in the Dallas, Texas-based company substantially, […] View the full post at: PlasmaTech Biopharmaceuticals (PTBI): Soros Fund Reveals 5.17 Percent Stake Related posts: George Soros Fund to Open Hong-Kong Office John Paulson’s Gold Fund Lost 14% in January France’s Sarkozy: Not against idea of Europe fund